Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
This clinical trial update reports on brain chemical receptor effects in patients with Panic Disorder and Posttraumatic Stress Disorder. Maj…
-
CLINICAL_TRIALS research · 2017-06-27Clinical Trial Update: Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research [Phase 2]
A Phase 2 clinical trial comparing cognitive therapy and behavior therapy for Panic Disorder, investigating different neural circuit mechani…
-
FDA approval · 2017-06-15FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by ROERIG, indicating an approved modification to th…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
This document reports the completion of a special drug use investigation for Paxil (paroxetine) at 20 mg/day in the treatment of panic disor…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
The document reports completion of a Special Drug Use Investigation for Paxil (paroxetine) in pediatric panic disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Primary Care Intervention Strategy for Anxiety Disorders [Phase 4]
Phase 4 trial update reporting results of a primary care intervention strategy for anxiety disorders, including PTSD and generalized anxiety…
-
FDA approval · 2017-04-28FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA has approved a supplemental application for paroxetine filed by Padagis US LLC. This notice indicates FDA approval of an amendment t…
-
FDA approval · 2017-04-05FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's original application for fluoxetine hydrochloride (fluoxetine) as a generic drug.
-
FDA approval · 2017-03-31FDA Approved: ALPRAZOLAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Alprazolam from Hikma Pharmaceuticals USA Inc., authorizing sale of a generic alprazolam pro…
-
FDA approval · 2017-03-24FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company. The action updates th…
-
FDA approval · 2017-03-24FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved a generic venlafaxine hydrochloride product from Westminster Pharmaceuticals, LLC under an Original Application. This approval …
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
A completed clinical trial update assessing whether phases of the menstrual cycle influence blood levels of lithium and sertraline in indivi…
-
FDA approval · 2017-01-20FDA Approved: PAROXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for Paroxetine, a generic selective serotonin reuptake inhibitor. The approval expa…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder [Phase 4]
Phase 4 clinical trial evaluating escitalopram for Irritable Bowel Syndrome in patients with panic disorder has completed; no efficacy resul…
-
FDA approval · 2017-01-04FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for PROZAC (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA label_change · 2017-01-04FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental labeling change for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The supplemental …
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC, likely related to labeling cha…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., indicating approval of a change to the exi…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental ANDA for venlafaxine by Heritage Pharmaceuticals (Avet) to bring a generic version to the market.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic venlafaxine) from Aurobindo Pharma Limited.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Alembic Pharmaceuticals Inc. under an approved ANDA.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product manufactured by Lannett Company, Inc.
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application from BluePoint Laboratories for Venlafaxine (venlafaxine hydrochloride), a generic antidepressan…
-
FDA approval · 2017-01-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride (venlafaxine HCl) from Teva Pharmaceuticals USA, Inc.